Cargando…
US public and private payer coverage for tobacco cessation treatments and barriers to accessing treatments
Autores principales: | Hussain, Radha, LeLaurin, Jennifer H., Salloum, Ramzi G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Publishing on behalf of the European Network for Smoking and Tobacco Prevention (ENSP)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112351/ https://www.ncbi.nlm.nih.gov/pubmed/35647416 http://dx.doi.org/10.18332/tpc/149483 |
Ejemplares similares
-
Implementation strategies for integrating tobacco cessation treatment
in cancer care: A qualitative study
por: LeLaurin, Jennifer H, et al.
Publicado: (2022) -
State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Accessing Treatments — United States, 2015–2017
por: DiGiulio, Anne, et al.
Publicado: (2018) -
State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Accessing Treatments — United States, 2008–2018
por: DiGiulio, Anne, et al.
Publicado: (2020) -
Variation in Private Payer Coverage of Rheumatoid Arthritis Drugs
por: Chambers, James D., et al.
Publicado: (2016) -
State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Coverage — United States, 2008–2014
por: Singleterry, Jennifer, et al.
Publicado: (2014)